Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05836051 · ClinicalTrials.gov registry record · NA
Testing the Effect of ENDS Flavors on Neurotransmission
A NA study, sponsored by Milton S. Hershey Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 36
- Enrollment target
NCT05836051 is a NA study that has completed, run by Milton S. Hershey Medical Center. The registered enrollment target is 36 participants.
The verdict
NCT05836051, a NA study, has completed, sponsored by Milton S. Hershey Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 36 participants
- Enrollment target
Study Summary
The overarching goal of this translational proposal is to determine if neuroactive flavor chemicals can enhance the addiction potential of electronic nicotine delivery systems (ENDS) by altering brain function and behavior.
Interventions
- OTHER Flavor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2025-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05836051
The ClinicalTrials.gov registry entry for NCT05836051 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Flavor is the first listed.
NCT05836051 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05836051 about?
NCT05836051 is a clinical study titled "Testing the Effect of ENDS Flavors on Neurotransmission". The overarching goal of this translational proposal is to determine if neuroactive flavor chemicals can enhance the addiction potential of electronic nicotine delivery systems (ENDS) by altering brain function and behavior.
What is the current status of trial NCT05836051?
This trial is currently completed. It is a NA study. The enrollment target is 36 participants. The study started on 2023-06-01. Estimated completion is 2025-07-31.
What interventions are being tested in trial NCT05836051?
The interventions under investigation include: Flavor (OTHER).
Who is sponsoring clinical trial NCT05836051?
This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.